Free Trial

The Cooper Companies, Inc. (COO) - What Are Analysts Saying About This Stock?

Cooper Companies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a “Hold” consensus on Cooper Companies, with 12 of 19 ratings at Hold, four Buy and three Sell; the average 12-month price target is $68.60. Recent calls were mixed, including Zacks’ downgrade to Strong Sell and Mizuho’s Outperform rating.
  • Cooper beat quarterly earnings expectations, reporting EPS of $1.15 versus $1.12 expected, but revenue of $1.07 billion fell short of the $1.10 billion forecast. The company also authorized a $3 billion share-repurchase plan.
  • Company directors bought shares recently, and insiders acquired 34,701 shares worth about $1.88 million over 90 days. Separately, Rosen Law Firm announced an investigation into potential securities claims; the notice does not establish wrongdoing.
  • MarketBeat previews top five stocks to own in December.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus rating of "Hold" from the nineteen ratings firms that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $68.60.

Several analysts have recently weighed in on the company. Zacks Research cut Cooper Companies from a "hold" rating to a "strong sell" rating in a report on Friday, September 11th. Bank of America lowered shares of Cooper Companies from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $80.00 to $65.00 in a report on Thursday, September 10th. Barclays upgraded shares of Cooper Companies to a "hold" rating in a report on Wednesday, October 7th. Mizuho set a $75.00 target price on shares of Cooper Companies and gave the stock an "outperform" rating in a research report on Thursday, September 10th. Finally, Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, September 12th.

View Our Latest Stock Report on Cooper Companies

Latest Cooper Companies News

Here's some of the latest news about COO:

  • Positive Sentiment: A recent article highlights Cooper’s relatively high cash yield, suggesting investors may be overlooking a potential source of value. The supplied information does not include the article’s supporting figures or analysis. Why Is Everyone Ignoring Cooper Companies Stock's High Cash Yield?
  • Negative Sentiment: Rosen Law Firm says it is investigating potential securities claims tied to allegations that Cooper may have provided materially misleading business information. The notices encourage affected investors to contact the firm; they do not establish wrongdoing or indicate that a claim has been proven. The investigation could nevertheless weigh on sentiment and raise concerns about potential legal costs or reputational impact. Rosen investigation notice Rosen investor notice

Insider Activity

In other Cooper Companies news, Director Paul Keel purchased 4,701 shares of the company's stock in a transaction dated Friday, September 11th. The stock was purchased at an average price of $53.18 per share, with a total value of $249,999.18. Following the completion of the purchase, the director owned 4,701 shares of the company's stock, valued at approximately $249,999.18. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Lawrence Kurzius purchased 10,000 shares of the business's stock in a transaction dated Monday, September 14th. The shares were acquired at an average price of $53.91 per share, for a total transaction of $539,100.00. Following the acquisition, the director owned 21,099 shares of the company's stock, valued at $1,137,447.09. This trade represents a 90.10% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders acquired 34,701 shares of company stock valued at $1,880,039. Insiders own 2.08% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Jump Financial LLC acquired a new position in shares of Cooper Companies in the third quarter worth approximately $8,653,000. Pathstone Holdings LLC boosted its holdings in Cooper Companies by 249.4% in the third quarter. Pathstone Holdings LLC now owns 88,292 shares of the medical device company's stock valued at $4,991,000 after acquiring an additional 63,022 shares during the last quarter. Marshall Wace LLP boosted its holdings in Cooper Companies by 175.4% in the third quarter. Marshall Wace LLP now owns 704,766 shares of the medical device company's stock valued at $39,840,000 after acquiring an additional 448,827 shares during the last quarter. Empowered Funds LLC boosted its holdings in Cooper Companies by 1,696.2% in the third quarter. Empowered Funds LLC now owns 149,950 shares of the medical device company's stock valued at $8,477,000 after acquiring an additional 141,602 shares during the last quarter. Finally, Tocqueville Asset Management L.P. increased its position in Cooper Companies by 9.5% during the 3rd quarter. Tocqueville Asset Management L.P. now owns 22,948 shares of the medical device company's stock valued at $1,297,000 after purchasing an additional 1,996 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO stock traded up $0.46 during midday trading on Friday, reaching $62.65. 1,574,266 shares of the stock were exchanged, compared to its average volume of 2,699,030. The stock has a market capitalization of $11.91 billion, a PE ratio of 21.38, a P/E/G ratio of 2.44 and a beta of 0.83. Cooper Companies has a 52 week low of $51.01 and a 52 week high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The company has a fifty day moving average price of $58.49 and a 200 day moving average price of $68.15.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. The business had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, analysts expect that Cooper Companies will post 4.53 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a stock buyback plan on Wednesday, September 9th that allows the company to repurchase $3 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 22.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's management believes its shares are undervalued.

About Cooper Companies

(Get Free Report)

CooperCompanies is a global medical device company focused on vision care and women's health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women's health and fertility care.

See Also

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines